miR-33a levels in hepatic and serum after chronic HBV-induced fibrosis

MicroRNA genetic variations: association with type 2 diabetes

(2013) Cinzia Ciccacci et al.   ACTA DIABETOLOGICA

MicroRNA-33a functions as a bone metastasis suppressor in lung cancer by targeting parathyroid hormone related protein

(2013) Po-Lin Kuo et al.   BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS

Beyond Secondary Structure: Primary-Sequence Determinants License Pri-miRNA Hairpins for Processing

(2013) Vincent C. Auyeung et al.   CELL

Profibrotic effect of miR-33a with Akt activation in hepatic stellate cells

(2013) Zhuo-Jian Li et al.   CELLULAR SIGNALLING

Differential MicroRNA Expression Profiles in Peripheral Arterial Disease

(2013) Philip W. Stather et al.   Circulation-Cardiovascular Genetics

Coexpression of Smad7 and UPA attenuates carbon tetrachloride-induced rat liver fibrosis

(2013) Baocan Wang et al.   MEDICAL SCIENCE MONITOR

A Regulatory Role for MicroRNA 33* in Controlling Lipid Metabolism Gene Expression

(2013) L. Goedeke et al.   MOLECULAR AND CELLULAR BIOLOGY

MicroRNAs in liver disease

(2013) Gyongyi Szabo et al.   Nature Reviews Gastroenterology & Hepatology

Treatment of HCV Infection by Targeting MicroRNA

(2013) Harry L.A. Janssen et al.   NEW ENGLAND JOURNAL OF MEDICINE

Hepatitis B virus infection status is an independent risk factor for multiple myeloma patients after autologous hematopoietic stem cell transplantation

(2013) Juan Li et al.   TUMOR BIOLOGY

microRNA involvement in human cancer

(2012) M. V. Iorio et al.   CARCINOGENESIS

Mir-33 regulates cell proliferation and cell cycle progression

(2012) Daniel Cirera-Salinas et al.   CELL CYCLE

The potential of microRNAs in liver fibrosis

(2012) Yong He et al.   CELLULAR SIGNALLING

MicroRNA-146a modulates TGF-beta1-induced hepatic stellate cell proliferation by targeting SMAD4

(2012) Yong He et al.   CELLULAR SIGNALLING

microRNA Biogenesis Pathway as a Therapeutic Target for Human Disease and Cancer

(2012) Francesca De Santa et al.   CURRENT PHARMACEUTICAL DESIGN

MicroRNA-221/222 upregulation indicates the activation of stellate cells and the progression of liver fibrosis

(2012) Tomohiro Ogawa et al.   GUT

Hepatic and serum levels of miR-122 after chronic HCV-induced fibrosis

(2012) Jonel Trebicka et al.   JOURNAL OF HEPATOLOGY

miR-133a mediates TGF-β-dependent derepression of collagen synthesis in hepatic stellate cells during liver fibrosis

(2012) Christoph Roderburg et al.   JOURNAL OF HEPATOLOGY

Inhibitory Smad7: Emerging Roles in Health and Disease

(2012) Marco A. Briones-Orta et al.   Current Molecular Pharmacology

New role of microRNA: carcinogenesis and clinical application in cancer

(2011) L. Zhao et al.   ACTA BIOCHIMICA ET BIOPHYSICA SINICA

Therapeutic targets in liver fibrosis

(2011) Jonathan A. Fallowfield   AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY

MicroRNA Epigenetics

(2011) Luckshman Bavan et al.   BIODRUGS

Noninvasive Tests for Fibrosis and Liver Stiffness Predict 5-Year Outcomes of Patients With Chronic Hepatitis C

(2011) Julien Vergniol et al.   GASTROENTEROLOGY

Biomarkers of liver fibrosis: What lies beneath the receiver operating characteristic curve?

(2011) Indra Neil Guha et al.   HEPATOLOGY

Circulating microRNA-21 as a novel biomarker for hepatocellular carcinoma

(2011) Yoshito Tomimaru et al.   JOURNAL OF HEPATOLOGY

Circulating microRNAs in hepatitis B virus-infected patients

(2011) F. Ji et al.   JOURNAL OF VIRAL HEPATITIS

Inhibition of miR-33a/b in non-human primates raises plasma HDL and lowers VLDL triglycerides

(2011) Katey J. Rayner et al.   NATURE

miR-33a/b contribute to the regulation of fatty acid metabolism and insulin signaling

(2011) A. Davalos et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Micro-RNA profiling reveals a role for miR-29 in human and murine liver fibrosis

(2010) Christoph Roderburg et al.   HEPATOLOGY

miR-21 mediates fibrogenic activation of pulmonary fibroblasts and lung fibrosis

(2010) Gang Liu et al.   JOURNAL OF EXPERIMENTAL MEDICINE

Correlation between microRNA expression levels and clinical parameters associated with chronic hepatitis C viral infection in humans

(2010) Rebecca T Marquez et al.   LABORATORY INVESTIGATION

Human primary cultured hepatic stellate cells can be cryopreserved

(2010) Anna Nakamura et al.   Medical Molecular Morphology

Circulating MicroRNAs, miR-21, miR-122, and miR-223, in patients with hepatocellular carcinoma or chronic hepatitis

(2010) Jian Xu et al.   MOLECULAR CARCINOGENESIS

Evolving challenges in hepatic fibrosis

(2010) Scott L. Friedman   Nature Reviews Gastroenterology & Hepatology

MicroRNA-33 and the SREBP Host Genes Cooperate to Control Cholesterol Homeostasis

(2010) S. H. Najafi-Shoushtari et al.   SCIENCE

MiR-33 Contributes to the Regulation of Cholesterol Homeostasis

(2010) K. J. Rayner et al.   SCIENCE

Regulation of TGF-  signaling by Smad7

(2009) X. Yan et al.   ACTA BIOCHIMICA ET BIOPHYSICA SINICA

MicroRNAs: Target Recognition and Regulatory Functions

(2009) David P. Bartel   CELL

Contemporary clinical research of traditional Chinese medicines for chronic hepatitis B in China: An analytical review

(2009) Lingyi Zhang et al.   HEPATOLOGY

Circulating microRNAs, potential biomarkers for drug-induced liver injury

(2009) K. Wang et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Hepatocyte-Specific Smad7 Expression Attenuates TGF-β–Mediated Fibrogenesis and Protects Against Liver Damage

(2008) Steven Dooley et al.   GASTROENTEROLOGY

Disruption of the Smad7 gene enhances CCI4-dependent liver damage and fibrogenesis in mice

(2008) Jafar Hamzavi et al.   JOURNAL OF CELLULAR AND MOLECULAR MEDICINE

Small non-coding RNAs in animal development

(2008) Giovanni Stefani et al.   NATURE REVIEWS MOLECULAR CELL BIOLOGY